AlphAIalphai — Financial news for AI agents
stocktitan.netJUL 274 min read$BRO

Brown & Brown posts $1.07 adjusted per-share earnings as organic revenue dips 0.7%

Brown & Brown (NYSE:BRO) reported unaudited Q2 2026 results: total revenues were $1.7 billion, up 30.4% YoY, while organic revenue fell 0.7%. Diluted EPS was $0.84 (+7.7%) and adjusted diluted EPS was $1.07 (+3.9%). For six months, revenues were $3.6 billion (+33.0%) and adjusted diluted EPS $2.46 (+6.0%).

Original reporting
stocktitan.net
Published Jul 27, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 9:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$BRO
Neutral
medium confidence
Mentioned
$BRO
Relevance
7/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$BRONeutralMed
01

Why it matters

Traders will likely focus on the tension between adjusted EPS strength and weaker organic revenue plus margin compression, alongside leverage/cash movement.

02

Market read

A fresh earnings print with specific adjusted EPS, organic revenue, margin, and balance-sheet changes creates a tradable setup for BRO around earnings expectations.

03

What to watch

Balance sheet changes (long-term debt up, cash down) could matter more for valuation and risk than the headline adjusted EPS, especially if leverage affects future financing costs.

Relevance 7/10Novelty 7/10Timing: after-hours earnings release for Q2 2026 (published 2026-07-27 21:00 UTC)

Background

The article is a Q2 2026 earnings release for Brown & Brown, including income statement highlights and a June 30 balance-sheet update.

Company-level read

Ticker impact

$BRONeutralMedium confidence
Context

Brown & Brown reported Q2 2026 adjusted EPS of $1.07 and organic revenue down 0.7%, plus margin compression and higher debt.

Expected impact

Near-term volatility likely, with traders weighing adjusted EPS strength against organic revenue and margin pressure.

Evidence & confidence

The release provides multiple directional datapoints: adjusted EPS up 3.9% and net income up 24.7%, while organic revenue fell 0.7% and income-tax margin and EBITDAC margin both declined; balance sheet shows long-term debt rising and cash declining.

Market effects

Sector

As an insurance broker, BRO’s organic revenue and margin trends can influence read-through expectations for broker demand and pricing.

Regional

No explicit regional breakdown provided; impact is primarily company-specific.

Global

No global macro or international regulatory catalyst cited beyond general organic revenue metrics.

Counterpoint

What could challenge this read

The organic revenue decline is small (-0.7%) versus strong total revenue growth (+30.4%), suggesting growth may be driven by acquisitions or contingents rather than core demand deterioration.

Key entities

  • public_company
    Brown & Brown, Inc.

    Insurance broker reporting Q2 2026 results, including adjusted EPS $1.07 and organic revenue -0.7%.

  • executive
    J. Powell Brown

    CEO quoted on momentum heading into the back half of the year.

Read at source← All news

Related articles

JUL 28
$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

financialcontent.com4 min
JUL 28
$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio

yahoo.com7 min
JUL 27
$BROMedAI 8/10

Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents

Brown & Brown, Inc. (NYSE:BRO) reported unaudited Q2 2026 results. Total revenues rose to $1.7 billion, up 30.4% year over year, while organic revenue fell 0.7%. Net income attributable to the company increased to $288 million, and diluted EPS was $0.84. For six months, revenues were $3.6 billion, up 33.0%.

thestarphoenix.com6 min
JUL 27
$BROMedAI 8/10

BROWN & BROWN, INC. (BRO): Results of Operations and Financial Condition

BROWN & BROWN, INC. (BRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bro-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents of 0.7%; diluted net incom

SEC EDGAR 8-K6 min
JUL 6
$BROMedAI 8/10

Why Brown & Brown (BRO) Stock Is Down Today

Brown & Brown (NYSE: BRO) shares fell about 2.6% after Morgan Stanley downgraded the stock to Underweight from Equalweight and cut its price target, citing concerns over organic growth reset, a softer pricing cycle, Florida exposure, and tougher competition and hiring. Barclays raised its target to $76 from $72. Shares traded near $68.04.

financialcontent.com5 min